APPLICATIONS PUBLISHED 26 JUNE 2002
Published: 1-Jan-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Formulation for menopausal women
F Hoffman-La Roche 1216025*
Compsns of tocol-soluble therapeutics
Sonus Pharmaceuticals; Constantinides, Panayiotis; Lambert, Karel; Tustian, Alexander; Nienstadt, Andrew 1216026*
Pharmaceutical compsn in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy
Cardion 1216027*
Biodegradable excipient systems for therapeutically active substances and method for producing the same
Glatt Process Technology 1216028*
Pharmaceutical carrier formulation
American Cyanamid 1216029*
Anti-inflammatory pharmaceutical formulations
Norton Healthcare 1216030*
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
Alza Corp 1216031*
Oral controlled release formulation
Novartis 1216032*
Vasopressin antagonist formulation and process
American Cyanamid 1216033*
Method and device for dispensing adhesive laminate segments from a movable primary support sheet situated on a secondary support sheet
LTS Lohmann Therapie-Systeme 1216034*
Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and production of the same
LTS Lohmann Therapie-Systeme 1216035*
Trandermal administration of N-(2,5-disubstituted phenyl)-N'-methyl guanidines
Alza Corp 1216036*
Methods and compsns for treating platelet-related disorders using MPL pathway inhibitory agents
Emory University 1216037*
Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
Aventis Pharma 1216038*
Novel combination for the treatment of sexual dysfunction
Bayer 1216039*
Agents for reducing cholesterol uptake and lipid uptake
Lipideon Biotechnology 1216040*
Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles
Dabur Research Foundation 1216042*
Retard form containing alpha-lipoic acid (derivatives)
SKW Trostberg 1216043*
Compsns having improved stability
Procter & Gamble 1216044*
Vasopressin agonist formulation and process
American Cyanamid 1216045*
Novel combination of loteprednol and antihistamines
Viatris 1216046*
Novel combination of loteprednol and beta2-adrenoreceptor agonists
Viatris 1216047*
Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
F Hoffmann-La Roche 1216048*
Method for treating muscular dystrophy using bone marrow cells
Children's Medical Centre Corp 1216049*
Compsns for reducing sympathomimetic-induced side effects by Seronoa repens extract
Imaginutrition 1216050*
Anti-cancer agent and method of treatment of cancer
Commonwealth Scientific and Industrial Research Organisation 1216051*
Combination of C1-INH ad lung surfactant for the treatment of respiratory disorders
Byk Gulden Lomberg; Aventis Behring; Vangerow, Burkhard; Rueckoldt, Horst; Marx, Gernot; Leuwer, Martin 1216052*
Influenza vaccine
SmithKline Beecham Biologicals 1216053*
Stress protein compsns and methods for prevention and treatment of cancer and infectious disease
Corixa Corp; Health Research 1216055*
Blocking immune response to a foreign antigen using an antagonist which binds to CD20
Genentech 1216056*
Stable calcitrol solution for packing in vials
Aaipharma 1216057*
Process for lessening polymorphic conversion of a drug
Alza Corp 1216058*
Compsn for IVF
Novo Nordisk 1216059*
Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
Biomedical Apherese Systeme 1216060*
